Automated liver cell processing facilitates large scale isolation and purification of porcine hepatocytes
- PMID: 7640419
Automated liver cell processing facilitates large scale isolation and purification of porcine hepatocytes
Abstract
An automated method for large scale isolation and purification of porcine hepatocytes is described. Liver cells were harvested by a two-step portal vein perfusion with ethylenediaminetetraacetate and collagenase. Hepatocyte purification was carried out using either a standard manual processing method (Procedure A) or an automated processing method using a filtration chamber and a programmable cell washer (Procedure B). Both methods produced high cell yields (Procedure A: 1.30 +/- 0.55 x 10(10) viable hepatocytes/liver; Procedure B: 1.38 +/- 0.32 x 10(10) viable hepatocytes/liver) and viability (Procedure A: 89 +/- 6.5%; Procedure B: 92 +/- 3.9%). Hepatocyte purity was significantly greater after Procedure B than after Procedure A (93.1 +/- 3.1% versus 83.1 +/- 3%, p < 0.01). Isolated hepatocytes by either method were morphologically intact, as demonstrated by transmission electron microscopy showing integrity of plasma membranes and intracellular organelles. Cultured hepatocytes isolated by either method were functionally intact, although those isolated by Procedure A showed significantly lower activity of microsomal 7-ethoxycoumarin-O-deethylase activity (p < 0.05) and mitochondrial succinate dehydrogenase activity (p < 0.01). In conclusion, use of the automated hepatocyte processing method resulted in efficient large scale preparation of porcine hepatocytes, with higher purity and greater retention of differentiated liver metabolic functions, and was found to be less time consuming and less labor intensive.
Similar articles
-
Automated large-scale production of porcine hepatocytes for bioartificial liver support.Transplant Proc. 1994 Dec;26(6):3505-6. Transplant Proc. 1994. PMID: 7998250 No abstract available.
-
Porcine hepatocytes from slaughterhouse organs. An unlimited resource for bioartificial liver devices.ASAIO J. 1995 Apr-Jun;41(2):189-93. ASAIO J. 1995. PMID: 7640425
-
Analysis of multivariables during porcine liver digestion to improve hepatocyte yield and viability for use in bioartificial liver support systems.Cell Transplant. 2000 May-Jun;9(3):329-36. Cell Transplant. 2000. PMID: 10972332
-
Application of isolated hepatocytes to studies of drug metabolism in large food animals.Xenobiotica. 1987 Mar;17(3):345-63. doi: 10.3109/00498258709043944. Xenobiotica. 1987. PMID: 3554786 Review.
-
[Cell culture and its application primary culture of human hepatocytes and its application].Gan To Kagaku Ryoho. 1992 Aug;19(9):1411-9. Gan To Kagaku Ryoho. 1992. PMID: 1503493 Review. Japanese.
Cited by
-
Preclinical Application of Reduced Manipulated Processing Strategy to Collect Transplantable Hepatocytes: A Pilot and Feasibility Study.J Pers Med. 2021 Apr 21;11(5):326. doi: 10.3390/jpm11050326. J Pers Med. 2021. PMID: 33919203 Free PMC article.
-
Clinical application of bioartificial liver support systems.Ann Surg. 2004 Aug;240(2):216-30. doi: 10.1097/01.sla.0000132986.75257.19. Ann Surg. 2004. PMID: 15273544 Free PMC article. Review.
-
Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure.Ann Surg. 2004 May;239(5):660-7; discussion 667-70. doi: 10.1097/01.sla.0000124298.74199.e5. Ann Surg. 2004. PMID: 15082970 Free PMC article. Clinical Trial.
-
Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial.Ann Surg. 1997 May;225(5):484-91; discussion 491-4. doi: 10.1097/00000658-199705000-00005. Ann Surg. 1997. PMID: 9193176 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources